Rahel M Büttler1, Frans Martens1, Flaminia Fanelli2, Hai T Pham3, Mark M Kushnir4, Marcel J W Janssen5, Laura Owen6, Angela E Taylor7, Tue Soeborg8, Marinus A Blankenstein1, Annemieke C Heijboer9. 1. Endocrine Laboratory, Department of Clinical Chemistry, VU University Medical Center, Amsterdam, Netherlands; 2. Endocrinology Unit and Center for Applied Biomedical Research, Department of Medical and Surgical Sciences, S. Orsola Malpighi Hospital, University of Bologna, Bologna, Italy; 3. Biocrates Life Sciences AG, Innsbruck, Austria; 4. Department of Pathology, University of Utah, Salt Lake City, UT; ARUP Institute for Clinical and Experimental Pathology, Salt Lake City, UT; 5. Laboratory of Clinical Chemistry and Hematology, VieCuri Medical Center Venlo, Netherlands; 6. Department of Clinical Biochemistry, University Hospital of South Manchester, Manchester, UK; 7. Centre for Endocrinology, Diabetes and Metabolism, School of Clinical and Experimental Medicine, University of Birmingham, UK; 8. Department of Growth and Reproduction, Rigshospitalet, Copenhagen University Hospital, Faculty of Health and Medical Sciences, University of Copenhagen, Denmark. 9. Endocrine Laboratory, Department of Clinical Chemistry, VU University Medical Center, Amsterdam, Netherlands; a.heijboer@vumc.nl.
Abstract
BACKGROUND: Recently, LC-MS/MS was stated to be the method of choice to measure sex steroids. Because information on the mutual agreement of LC-MS/MS methods is scarce, we compared 7 published LC-MS/MS methods for the simultaneous measurement of testosterone, androstenedione, and dehydroepiandrosterone (DHEA). METHODS: We used 7 published LC-MS/MS methods to analyze in duplicate 55 random samples from both men and women. We performed Passing-Bablok regression analysis and calculated Pearson correlation coefficients to assess the agreement of the methods investigated with the median concentration measured by all methods, and we calculated the intraassay CV of each method derived from duplicate results and the CVs between the methods. RESULTS: Median concentrations of testosterone were 0.22-1.36 nmol/L for women and 8.27-27.98 nmol/L for men. Androstenedione and DHEA concentrations were 0.05-5.53 and 0.58-18.04 nmol/L, respectively. Intraassay CVs were 2.9%-10%, 1.2%-8.8%, 2.7%-13%, and 4.3%-16% for testosterone in women, testosterone in men, androstenedione, and DHEA. Slopes of the regression lines calculated by Passing-Bablok regression analysis were 0.92-1.08, 0.92-1.08, 0.90-1.13, and 0.91-1.41 for all testosterone values, testosterone in women, androstenedione, and DHEA. Intermethod CVs were 14%, 8%, 30%, and 22% for testosterone in women, testosterone in men, androstenedione, and DHEA. CONCLUSIONS: In general, the LC-MS/MS methods investigated show reasonable agreement. However, some of the assays show differences in standardization, and others show high variation.
BACKGROUND: Recently, LC-MS/MS was stated to be the method of choice to measure sex steroids. Because information on the mutual agreement of LC-MS/MS methods is scarce, we compared 7 published LC-MS/MS methods for the simultaneous measurement of testosterone, androstenedione, and dehydroepiandrosterone (DHEA). METHODS: We used 7 published LC-MS/MS methods to analyze in duplicate 55 random samples from both men and women. We performed Passing-Bablok regression analysis and calculated Pearson correlation coefficients to assess the agreement of the methods investigated with the median concentration measured by all methods, and we calculated the intraassay CV of each method derived from duplicate results and the CVs between the methods. RESULTS: Median concentrations of testosterone were 0.22-1.36 nmol/L for women and 8.27-27.98 nmol/L for men. Androstenedione and DHEA concentrations were 0.05-5.53 and 0.58-18.04 nmol/L, respectively. Intraassay CVs were 2.9%-10%, 1.2%-8.8%, 2.7%-13%, and 4.3%-16% for testosterone in women, testosterone in men, androstenedione, and DHEA. Slopes of the regression lines calculated by Passing-Bablok regression analysis were 0.92-1.08, 0.92-1.08, 0.90-1.13, and 0.91-1.41 for all testosterone values, testosterone in women, androstenedione, and DHEA. Intermethod CVs were 14%, 8%, 30%, and 22% for testosterone in women, testosterone in men, androstenedione, and DHEA. CONCLUSIONS: In general, the LC-MS/MS methods investigated show reasonable agreement. However, some of the assays show differences in standardization, and others show high variation.
Authors: L Roli; D Santi; S Belli; S Tagliavini; S Cavalieri; M C De Santis; E Baraldi; F Fanelli; M Mezzullo; A R Granata; U Pagotto; R Pasquali; V Rochira; C Carani; M Simoni; T Trenti Journal: J Endocrinol Invest Date: 2017-03-21 Impact factor: 4.256
Authors: Benjamin P Magyar; Maristella Santi; Grit Sommer; Jean-Marc Nuoffer; Alexander Leichtle; Michael Grössl; Christa E Fluck Journal: J Endocr Soc Date: 2022-05-06
Authors: Junyan Shi; Rachel Bird; Michael W Schmeling; Andrew N Hoofnagle Journal: J Chromatogr B Analyt Technol Biomed Life Sci Date: 2021-10-04 Impact factor: 3.318
Authors: Thomas G Papathomas; Na Sun; Vasileios Chortis; Angela E Taylor; Wiebke Arlt; Susan Richter; Graeme Eisenhofer; Gerard Ruiz-Babot; Leonardo Guasti; Axel Karl Walch Journal: Histochem Cell Biol Date: 2019-02-06 Impact factor: 4.304
Authors: Sergio Varela Kellesarian; Hans Malmstrom; Tariq Abduljabbar; Fahim Vohra; Tammy Varela Kellesarian; Fawad Javed; Georgios E Romanos Journal: Am J Mens Health Date: 2016-09-21
Authors: Marie Lebbe; Angela E Taylor; Jenny A Visser; Jackson C Kirkman-Brown; Teresa K Woodruff; Wiebke Arlt Journal: Endocrinology Date: 2017-05-01 Impact factor: 4.736
Authors: Michael W O'Reilly; Punith Kempegowda; Carl Jenkinson; Angela E Taylor; Jonathan L Quanson; Karl-Heinz Storbeck; Wiebke Arlt Journal: J Clin Endocrinol Metab Date: 2017-03-01 Impact factor: 5.958
Authors: L Antonio; S Pauwels; M R Laurent; D Vanschoubroeck; I Jans; J Billen; F Claessens; B Decallonne; Diane De Neubourg; P Vermeersch; D Vanderschueren Journal: Int J Endocrinol Date: 2018-09-10 Impact factor: 3.257
Authors: Letícia Ribeiro Oliveira; Carlos Alberto Longui; Guilherme Guaragna-Filho; José Luiz Costa; Rafael Lanaro; David Antônio Silva; Maria Izabel Chiamolera; Maricilda Palandi de Mello; André Moreno Morcillo; Andrea Trevas Maciel-Guerra; Gil Guerra-Junior Journal: Endocr Connect Date: 2020-11 Impact factor: 3.335